Can-Fite BioPharma reports net loss widens to $9.83 million in 2025
Tweet Send to a Friend
Can-Fite BioPharma Ltd. (NYSE American: CANF) reported a net loss of $9.83 million for 2025, compared to $7.88 million in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
